Oncodesign Precision Medicine S.A Logo

Oncodesign Precision Medicine S.A Claim profile

ISIN: FR001400CM63 | Ticker: ALOPM | LEI: 969500ZDX1IY47LDL876

About Oncodesign Precision Medicine S.A

Company Description

OPM is a technological company specialized in precision medicine.

OPM's mission is to bring innovative therapeutic and diagnostic solutions to treat therapeutic resistance and metastasis evolution. The patient is at the centre of our reflexion, of our unique innovative model, and our investments.

For OPM "our collective success is paramount", there can be no value creation without exchange, without dialogue. The value creation resulting for us from reciprocity, i.e. balanced and fair exchanges at all levels, whether between internal collaborators, or with our partners, therapists, patients, experts and investors.

Year founded


Served area



18 rue Jean Mazen, 21000 Dijon – France

Filings & Publications

Sign up and we will inform you!

Insider Trades

Sign up and we will inform you!

Shareholder information

Shares outstanding



Oct. 5, 2022

Stock exchange(s)

Euronext Paris

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.